Federal Nat (FNMAT) reported $29.0B in revenue for fiscal year 2025, down 0.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
A highly leveraged balance sheet turns a tiny asset return of 0.3% into a double-digit equity return.
With revenue still near$29B , operating cash flow rebounded to$24.0B after turning negative the year before, showing that near-term cash generation is driven more by balance-sheet movements than by sales. At the same time, ROA stayed at just0.3% while ROE was13.2% , the signature of a business where leverage, not asset yield, does most of the work.
Liabilities of
Retained earnings were still
Financial Health Signals
We are recalculating Federal Nat's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.
Federal Nat passes 6 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, both operating efficiency signals pass.
For every $1 of reported earnings, Federal Nat generates $1.67 in operating cash flow ($24.0B OCF vs $14.4B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Federal Nat generated $29.0B in revenue in fiscal year 2025. This represents a decrease of 0.4% from the prior year.
Federal Nat reported $14.4B in net income in fiscal year 2025. This represents a decrease of 15.4% from the prior year.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Federal Nat held $42.6B in cash against $4.2T in long-term debt as of fiscal year 2025.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Federal Nat's net profit margin was 49.6% in fiscal year 2025, showing the share of revenue converted to profit. This is down 8.8 percentage points from the prior year.
Federal Nat's ROE was 13.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 4.8 percentage points from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Capital Allocation
None of these metrics is reported for fiscal year 2025.
FNMAT Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $29.2B | $29.0B-0.4% | $29.1B+0.1% | $29.0B-2.3% | $29.7B-0.7% | $29.9B+18.2% | $25.3B+15.9% | $21.9B+0.1% | $21.8B-4.9% | $23.0B+3.1% | $22.3B-2.2% | $22.8B-12.0% | $25.9B-78.0% | $117.5B-9.0% | $129.2B-9.6% | $142.9B |
| SG&A Expenses | $3.3B | $3.6B-1.1% | $3.6B+5.1% | $3.4B+7.8% | $3.2B+4.3% | $3.1B-0.1% | $3.1B+1.5% | $3.0B-1.2% | $3.1B+11.8% | $2.7B-0.1% | $2.7B-10.1% | $3.0B+9.8% | $2.8B+9.1% | $2.5B+7.5% | $2.4B-0.1% | $2.4B |
| Interest Expense | $131.0B | $130.0B+6.7% | $121.8B+9.8% | $110.9B+22.1% | $90.9B+29.7% | $70.1B-15.3% | $82.7B-16.4% | $98.9B+2.8% | $96.2B+7.9% | $89.1B+5.2% | $84.7B-3.8% | $88.0B-6.8% | $94.4B-0.7% | $95.1B-11.6% | $107.7B-12.9% | $123.7B |
| Income Tax | $3.6B | $3.6B-15.7% | $4.3B-5.7% | $4.5B+37.4% | $3.3B-42.7% | $5.8B+87.8% | $3.1B-10.0% | $3.4B-17.5% | $4.1B-74.1% | $16.0B+165.5% | $6.0B+14.6% | $5.3B-24.3% | $6.9B+115.3% | -$45.4B | $0+100.0% | -$90.0M |
| Net Income | $14.4B | $14.4B-15.4% | $17.0B-2.5% | $17.4B+34.7% | $12.9B-41.7% | $22.2B+87.9% | $11.8B-16.6% | $14.2B-11.3% | $16.0B+547.9% | $2.5B-80.0% | $12.3B+12.4% | $11.0B-22.9% | $14.2B-83.1% | $84.0B+387.5% | $17.2B+202.2% | -$16.9B |
| EPS (Diluted) | — | $0.00 | $0.00 | $0.00 | $0.00-100.0% | $0.01 | $0.00-100.0% | $0.03 | $0.57+150.9% | -$1.12-11300.0% | $0.01+120.0% | -$0.05+73.7% | -$0.19+24.0% | -$0.25-204.2% | $0.24 | -$4.61 |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income.
TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
FNMAT Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.3T-0.7% | $4.3T+0.6% | $4.3T+0.5% | $4.3T+1.8% | $4.2T+6.1% | $4.0T+13.8% | $3.5T+2.5% | $3.4T+2.2% | $3.3T+1.8% | $3.3T+2.1% | $3.2T-0.8% | $3.2T-0.7% | $3.3T+1.5% | $3.2T+0.3% | $3.2T |
| Cash & Equivalents | $42.6B+9.6% | $38.9B+8.5% | $35.8B-38.2% | $58.0B+36.6% | $42.4B+10.7% | $38.3B+81.0% | $21.2B-17.1% | $25.6B-20.4% | $32.1B+27.3% | $25.2B+71.9% | $14.7B-33.4% | $22.0B+14.5% | $19.2B-8.9% | $21.1B+20.4% | $17.5B |
| Total Liabilities | $4.2T-1.1% | $4.3T+0.2% | $4.2T+0.1% | $4.2T+1.5% | $4.2T+5.6% | $4.0T+13.5% | $3.5T+2.2% | $3.4T+1.9% | $3.3T+2.1% | $3.3T+2.0% | $3.2T-0.8% | $3.2T-0.5% | $3.3T+1.4% | $3.2T0.0% | $3.2T |
| Long-Term Debt | $4.2T-1.4% | $4.2T+0.3% | $4.2T-0.1% | $4.2T+1.4% | $4.2T+5.9% | $3.9T+14.0% | $3.4T+2.2% | $3.4T+2.1% | $3.3T+2.2% | $3.2T+3.2% | $3.1T+0.3% | $3.1T-1.4% | $3.2T+2.6% | $3.1T+1.4% | $3.0T |
| Total Equity | $109.0B+15.2% | $94.7B+21.9% | $77.7B+28.9% | $60.3B+27.3% | $47.4B+87.5% | $25.3B+72.9% | $14.6B+134.1% | $6.2B+269.3% | -$3.7B-160.7% | $6.1B+50.6% | $4.0B+9.5% | $3.7B-61.4% | $9.5B+32.8% | $7.2B+255.3% | -$4.6B |
| Retained Earnings | -$24.3B+37.2% | -$38.6B+30.5% | -$55.6B+23.8% | -$73.0B+15.0% | -$85.9B+20.5% | -$108.1B+9.0% | -$118.8B+6.7% | -$127.3B+4.8% | -$133.8B-7.7% | -$124.3B+2.1% | -$126.9B+0.5% | -$127.6B-5.3% | -$121.2B+1.3% | -$122.8B+4.4% | -$128.4B |
Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Goodwill, Current Liabilities.
FNMAT Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $37.0B | $24.0B+328.0% | -$10.5B-188.5% | $11.9B-72.9% | $43.8B-7.2% | $47.2B+164.7% | -$72.9B-1434.2% | -$4.8B-311.5% | $2.2B-46.6% | $4.2B+529.9% | -$980.0M+85.3% | -$6.7B-398.7% | -$1.3B-110.4% | $12.9B-65.1% | $37.0B+342.8% | -$15.2B |
| Investing Cash Flow | $195.1B | $186.9B+22.8% | $152.2B+27.6% | $119.3B+32.3% | $90.1B-0.8% | $90.8B+240.5% | $26.7B-87.1% | $207.1B+37.3% | $150.9B-18.2% | $184.4B-20.2% | $231.1B-7.0% | $248.3B+10.5% | $224.7B-50.4% | $452.8B-14.2% | $527.7B+13.6% | $464.4B |
| Financing Cash Flow | -$224.8B | -$206.8B-50.8% | -$137.2B-5.4% | -$130.2B+15.9% | -$154.7B-6.7% | -$145.1B-244.4% | $100.5B+152.8% | -$190.3B-16.1% | -$163.9B+14.0% | -$190.5B+10.7% | -$213.4B+14.3% | -$249.0B-12.9% | -$220.5B+52.8% | -$467.5B+16.7% | -$561.1B-25.0% | -$448.9B |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.
TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
FNMAT Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 49.6%-8.8pp | 58.4%-1.5pp | 59.9%+16.5pp | 43.5%-30.6pp | 74.1%+27.4pp | 46.6%-18.2pp | 64.8%-8.3pp | 73.1%+62.4pp | 10.7%-44.6pp | 55.3%+7.2pp | 48.1%-6.8pp | 54.9%-16.5pp | 71.4%+58.1pp | 13.3%+25.1pp | -11.8% |
| Return on Equity | 13.2%-4.8pp | 17.9%-4.5pp | 22.4%+1.0pp | 21.4%-25.4pp | 46.8%+0.1pp | 46.7%-50.2pp | 96.9%-158.8pp | 255.8% | N/A | 202.8%-69.0pp | 271.8%-114.3pp | 386.1%-493.9pp | 880.0%+640.2pp | 239.8% | N/A |
| Return on Assets | 0.3%-0.1pp | 0.4%0.0pp | 0.4%+0.1pp | 0.3%-0.2pp | 0.5%+0.2pp | 0.3%-0.1pp | 0.4%-0.1pp | 0.5%+0.4pp | 0.1%-0.3pp | 0.4%0.0pp | 0.3%-0.1pp | 0.4%-2.1pp | 2.6%+2.0pp | 0.5%+1.0pp | -0.5% |
| Debt-to-Equity | 38.12-6.4x | 44.55-9.6x | 54.14-15.7x | 69.87-17.9x | 87.75-67.6x | 155.33-80.2x | 235.54-304.1x | 539.59 | N/A | 531.50-244.1x | 775.61-71.0x | 846.63+515.4x | 331.21-97.7x | 428.90 | N/A |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.
Where Federal Nat Ranks
Frequently Asked Questions
What is Federal Nat's annual revenue?
Federal Nat (FNMAT) reported $29.0B in total revenue for fiscal year 2025. This represents a -0.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Federal Nat's revenue growing?
Federal Nat (FNMAT) revenue declined by 0.4% year-over-year, from $29.1B to $29.0B in fiscal year 2025.
Is Federal Nat profitable?
Yes, Federal Nat (FNMAT) reported a net income of $14.4B in fiscal year 2025, with a net profit margin of 49.6%.
How much debt does Federal Nat have?
As of fiscal year 2025, Federal Nat (FNMAT) had $42.6B in cash and equivalents against $4.2T in long-term debt.
What is Federal Nat's net profit margin?
Federal Nat (FNMAT) had a net profit margin of 49.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Federal Nat's return on equity (ROE)?
Federal Nat (FNMAT) has a return on equity of 13.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Federal Nat's operating cash flow?
Federal Nat (FNMAT) generated $24.0B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Federal Nat's total assets?
Federal Nat (FNMAT) had $4.3T in total assets as of fiscal year 2025, including both current and long-term assets.
What is Federal Nat's debt-to-equity ratio?
Federal Nat (FNMAT) had a debt-to-equity ratio of 38.12 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Federal Nat's return on assets (ROA)?
Federal Nat (FNMAT) had a return on assets of 0.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Federal Nat's Piotroski F-Score?
Federal Nat (FNMAT) has a Piotroski F-Score of 6 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Federal Nat's earnings high quality?
Federal Nat (FNMAT) has an earnings quality ratio of 1.67x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.